Exposure-Based Treatment for Obsessive Compulsive Disorder

The Oxford Handbook of Obsessive Compulsive and Spectrum Disorders

Volumn , Issue , 2012, Pages

  Abramowitz, Jonathan S ^a   Taylor, Steven ^b   McKay, Dean ^c  

^a The University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c FORDHAM UNIVERSITY   (United States)

Author keywords

Cognitive therapy; D cycloserine; Emotional processing; Exposure and response prevention; Fear extinction; Obsessive compulsive disorder; Serotonin reuptake inhibitors

Indexed keywords

EID: 84873264930     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/oxfordhb/9780195376210.013.0071     Document Type: Chapter

References (96)

1. Abramowitz, J. S. (1996). Variants of exposure and response prevention in the treatment of obsessive-compulsive disorder: a meta-analysis. Behavior Therapy, 27, 583-600.
2. Abramowitz, J. S. (2006). Understanding and treating obsessive-compulsive disorder: A cognitive-behavioral approach. Mahwah, NJ: Erlbaum.
3. Abramowitz, J. S., Deacon, B. J., & Whiteside, S. P. (2011). Exposure therapy for anxiety: Principles and practice. New York: Guilford.
4. Abramowitz, J. S., & Foa, E. (2000). Does comorbid major depressive disorder influence outcome of exposure and response prevention for OCD? Behavior Therapy, 31, 795-800.
5. Abramowitz, J. S., Foa, E. B., & Franklin, M. E. (2003). Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice-weekly sessions. Journal of Consulting and Clinical Psychology, 71, 394-398.
6. Abramowitz, J. S., Franklin, M. E., & Foa, E. B. (2002). Empirical status of cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analytic review. Romanian Journal of Cognitive and Behavioral Psychotherapies, 2, 89-104.
7. Abramowitz, J. S., Franklin, M. E., Schwartz, S. A., & Furr, J. M. (2003). Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology, 71, 1049-1057.
8. Abramowitz, J. S., Franklin, M. E., Street, G. P., Kozak, M. J., & Foa, E. B. (2000). Effects of comorbid depression on response to treatment for obsessive-compulsive disorder. Behavior Therapy, 31, 517-528.
9. Abramowitz, J. S., Franklin, M., Zoellner, L., & DiBernardo, C. (2002). Treatment compliance and outcome in obsessive-compulsive disorder. Behavior Modification, 26, 447-463.
10. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., Text revision) (DSM-IV-TR). Washington, DC: Author.
11. Anderson, R. A. & Rees, C. S. (2007) Group versus individual cognitive-behavioural treatment for obsessivecompulsive disorder: A controlled trial. Behaviour Research and Therapy, 45, 123-137
12. American Psychiatric Association. (2007). Practice guidelines: Treatment of patients with obsessive-compulsive disorder. Author. Available at: http://www.psychiatryonline.com/pracGuide/pracGuideTopic_10.aspx.
13. Baer, L. (1994). Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. Journal of Clinical Psychiatry, 55, 18-23.
14. Bouton, M. E. (1993). Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychological Bulletin, 114, 90-99.
15. Bouton, M. E. (2002). Context, ambiguity, and unlearning: Sources of relapse after behavioral extinction. Biological Psychiatry, 52, 976-986.
16. Chambless, D. L., & Steketee, G. (1999). Expressed emotion and behavior therapy outcome: A prospective study with obsessive-compulsive and agoraphobic outpatients. Journal of Consulting and Clinical Psychology, 67, 658-665.
17. Christensen, H., Hadzi-Pavlovic, D., Andrews, G., & Mattick, R. (1987). Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: A quantitative review. Journal of Consulting and Clinical Psychology, 55, 701-711.
18. Clark, D. M. (1999). Anxiety disorders: why they persist and how to treat them. Behaviour Research & Therapy, 37, S5-S27.
19. Cordioli, V., Heldt, A., Braga, E., Bochi, D., Margis, R., Basso de Sousa, M., Fonseca Tonello, J., Gus Manfro, G., & Kapczinski, F. (2003). Cognitive-behavioral group therapy in obsessive-compulsive disorder: A randomized clinical trial. Psychotherapy and Psychosomatics, 72, 211-216.
20. Cottraux, J., Mollard, E., Bouvard, M., Marks, I., Sluys, M., Nury, A., Douge, R., & Ciadella, P. (1990). A controlled study of fluvoxamine and exposure in obsessive compulsive disorder. International Journal of Clinical Psychopharmacology, 5, 17-30.
21. Cottraux, J., Note, I., Yao, S. N., Lafont, S., Note, B., Mollard, E., Bouvard, M., Sauteraud, A., Bourgeois, M., & Dartigues, J.-F. (2001). A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychotherapy and Psychosomatics, 70, 288-297.
22. Craske, M. G. & Mystkowski, J. L. (2006). Exposure therapy and extinction: Clinical studies. In M.G. Craske, D. Hermans, & D. Vansteenwegen (Eds.), Fear and learning: From basic processes to clinical implications (pp. 217-233). Washington, DC: American Psychological Association.
23. Dollard, J., & Miller, N. E. (1950). Personality and psychotherapy: An analysis in terms of learning, thinking, and culture. New York: McGraw-Hill.
24. Eddy, K., Dutra, L., Bradley, R., & Weston, D. (2004). A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clinical Psychology Review, 24, 1011-1030.
25. Ellis, A. (1962). Reason and emotion in psychotherapy. Secaucus NJ: Lyle Stuart.
26. Emmelkamp, P. M. G., & Beens, H. (1991). Cognitive therapy with obsessive-compulsive disorder: A comparative evaluation. Behaviour Research and Therapy, 29, 293-300.
27. Emmelkamp, P. M. G., & Kraanen, J. (1977). Therapist-controlled exposure in vivo versus self-controlled exposure in vivo: a comparison with obsessive-compulsive patients. Behaviour Research and Therapy, 15, 491-195.
28. Emmelkamp, P. M. G., Visser, B., & Hoekstra, R. J. (1988). Cognitive therapy vs. exposure in vivo in the treatment of obsessive-compulsives. Cognitive Therapy and Research, 12, 103-114.
29. Fals-Stewart, W., Marks, A. P., & Schafer, J. (1993). A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder. The Journal of Nervous and Mental Disease, 181(3), 189-193.
30. Foa, E. B. (1979). Failure in treating obsessive-compulsives. Behaviour Research and Therapy, 17, 169-176.
31. Foa, E. B., Abramowitz, J. S., Franklin, M. E., & Kozak, M. J. (1999). Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsive disorder. Behavior Therapy, 30, 717-724.
32. Foa, E. B., Huppert, J. & Cahill, S. (2006). Emotional processing theory: An update. In: B.O. Rothbaum (Ed.). Pathological anxiety: Emotional processing in etiology and treatment (3-24). Guilford, New York.
33. Foa, E. B., & Goldstein, A. (1978). Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behavior Therapy, 9, 821-829.
34. Foa, E. B., Grayson, J. B., Steketee, G. S., Doppelt, H. G., Turner, R. M., & Latimer, P. R. (1983). Success and failure in the behavioral treatment of obsessive-compulsives. Journal of Consulting and Clinical Psychology, 51, 287-297.
35. Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99, 20-35.
36. Foa, E. B., & Kozak, M. J. (1995). DSM-IV field trial: Obsessive-compulsive disorder. American Journal of Psychiatry, 152(1), 90-96.
37. Foa, E. B., & Kozak, M. J. (1996). Psychological treatment for obsessive-compulsive disorder. In M. R. Mavissakalian & R. F. Prien (Eds.), Long-term treatments of anxiety disorders (pp. 285-309). Washington, DC: American Psychiatric Press, Inc.
38. Foa, E., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., et al. (2005). Randomized, placebocontrolled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 162, 151-161.
39. Foa, E. B., Steketee, G, Grayson, J., Turner, R., & Lattimer, P. (1984). Deliberate exposure and blocking of obsessive-compulsive rituals: Immediate and long-term effects. Behavior Therapy, 15, 450-472.
40. Foa, E. B., Steketee, G., & Milby, J. (1980). Differential effects of exposure and response prevention in obsessivecompulsive washers. Journal of Consulting and Clinical Psychology, 48, 71-79.
41. Foa, E. B., Steketee, G., Turner, R. M., & Fischer, S. C. (1980). Effects of imaginal exposure to feared disasters in obsessive-compulsive checkers. Behaviour Research and Therapy, 18, 449-455.
42. Franklin, M. E., Abramowitz, J. S., Foa, E. B., Kozak, M. J., & Levitt, J. T. (2000). Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples. Journal of Consulting and Clinical Psychology, 68(4), 594-602.
43. Freeston, M. H., & Ladouceur, R. (1999). Exposure and response prevention for obsessive thoughts. Cognitive & Behavioral Practice, 6, 362-383.
44. Freeston, M. H., Ladouceur, R., Gagnon, F., Thibodeau, N., Rheaume, J., Letarte, H., et al. (1997). Cognitivebehavioral treatment of obsessive thoughts: a controlled study. Journal of Consulting and Clinical Psychology, 65, 405-413.
45. Friedman, S., Smith, L. C., Halpern, B., Levine, C., Paradis, C., Viswanathan, R., et al. (2003). Obsessive-compulsive disorder in a multi-ethnic urban outpatient clinic: initial presentation and treatment outcome with exposure and ritual prevention. Behavior Therapy, 34, 397-410.
46. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., & Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale: validity. Archives of General Psychiatry, 46, 1012-1016.
47. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., Heninger, G. R., & Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale: development, use, and reliability. Archives of General Psychiatry, 46, 1006-1011.
48. Grayson, J. B., Foa, E. B., & Steketee, G. (1982). Habituation during exposure treatment: Distraction vs attentionfocusing. Behaviour Research and Therapy, 20, 323-328.
49. Greist, J. H., Jefferson, J. W., Kobak, K. A., Katzelnick, D. J., & Serlin, R. C. (1995). Efficacy and tolerability of serotonin transport inhibitors in obsessive compulsive disorder: A meta-analysis. Archives of General Psychiatry, 52, 53-60.
50. Hiss, H., Foa, E. B., & Kozak, M. J. (1994). Relapse prevention program for treatment of obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology, 62, 801-808.
51. Hodgson, R., Rachman, S., & Marks, I. (1972). The treatment of chronic obsessive-compulsive neurosis: follow-up and further findings. Behaviour Research and Therapy, 10, 181-189.
52. Hofmann, S.G., Meuret, A.E., Smits, J.A., Simon, N.M., Pollack, M.H., Eisenmenger, K., et al. (2006): Augmentation of exposure therapy with D-Cycloserine for social anxiety disorder. Archives of General Psychiatry, 63, 298-304.
53. Hohagen, F., Winkelmann, G., Rasche-Rauchle, H., Hand, I., Konig, A., Munchau, N., Hiss, H., Geiger-Kabisch, C., Kappler, C., Schramm, P., Rey, E., Aldenhoff, J., & Berger, M. (1998). Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. British Journal of Psychiatry, 173, 71-78.
54. Johnstone, J. & Page, A. (2004). Attention to phobic stimuli during exposure: The effect of distraction on anxiety reduction, self-efficacy and perceived control, Behaviour Research and Therapy, 42, 249-275.
55. Kampman, M., Keijsers, G. P. J., Hoogduin, C. A. L., & Verbank, M. J. P. M. (2002). Addition of cognitive-behavior therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. ACTA Psychiatrica Scandinavica, 106, 314-319.
56. Kringlen, E. (1965). Obsessional neurotics: A long-term follow-up. British Journal of Psychiatry, 111, 709-722.
57. Kushner, M. G., Kim, S. W., Donahue, C., Thuras, P., Kotlyar, M., et al. (2007). D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biological Psychiatry, 62, 835-838.
58. Kushner, M. G., Kim, S-W., Donahue, C., Thuras, P., Adson, D., Kvtlyar, M., McCabe, J., Peterson, J., & Foa, E. (2007). D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biological Psychiatry, 62, 835-838.
59. Lang, P. (1977). Imagery in therapy: An information processing analysis of fear, Behavior Therapy, 8, 862-886.
60. Lax, T., Basoglu, M., & Marks, I. M. (1992). Expectancy and compliance as predictors of outcome in obsessivecompulsive disorder. Behavioural Psychotherapy, 20, 257-266.
61. LeDoux, J. E. (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23, 155-184.
62. Lindsay, M., Crino, R., & Andrews, G. (1997). Controlled trial of exposure and response prevention in obsessivecompulsive disorder. British Journal of Psychiatry, 171, 135-139.
63. March, J. S., Frances, A., Carpenter, D., Kahn, D. (1997). The expert consensus guidelines series: Treatment of obsessive-compulsive disorder. Journal of Clinical Psychiatry, 58 (Suppl. 4).
64. Mataix-Cols, D., Marks, I. M., Greist, J. H., Kobak, K. A., & Baer, L. (2002). Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychotherapy and Psychosomatics, 71, 255-262.
65. McLean, P. D., Whittal, M. L., Thordarson, D. S., Taylor, S., Sochting, I., Koch, W. J., Paterson, R., & Anderson, K. W. (2001). Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology, 69, 205-214.
66. McNally, R. J. (2007). Mechanisms of exposure therapy: How neuroscience can improve psychological treatments for anxiety disorders. Clinical Psychology Review, 27, 750-759.
67. Meyer, V. (1966). Modification of expectations in cases with obsessional rituals. Behaviour Research and Therapy, 4, 273-280.
68. Meyer, V., Levy, R., & Schnurer, A. (1974). The behavioral treatment of obsessive-compulsive disorders. In H. R. Beech (Ed.), Obsessional states (pp. 233-258). London: Methuen.
69. Montgomery, S. A., McIntyre, A., Ostenheider, M., Sarteschi, P., Zitterl, W., Zohar, J., Birkett, M., & Wood, A. J. (1993). A double-blind placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. European Neuropsychopharmacology, 3, 142-152.
70. Mowrer, O. (1960). Learning theory and behavior. New York: Wiley.
71. Nakatani, E., Nakagawa, A., Nakao, T., Yoshizato, C., Nabeyama, M., Kudo, A., Isomura, K., Kato, N., Yoshioka, K., & Kawamoto, M. (2005). A randomized trial of Japanese patients with obsessive-compulsive disorder: effectiveness of behavior therapy and fluvoxamine. Psychotherapy and Psychosomatics, 74, 269-276.
72. O'Connor, K., Todorov, C., Robillard, S., Borgeat, F., & Brault, M. (1999). Cognitive-behaviour therapy and medication in the treatment of obsessive-compulsive disorder: A controlled study. Canadian Journal of Psychiatry, 44, 64-71.
73. Persons, J. B., & Silberschatz, G. (1998). Are results of randomized controlled trials useful to psychotherapists? Journal of Consulting and Clinical Psychology, 66, 126-135.
74. Rachman, S. (1980) Emotional processing. Behaviour Research and Therapy, 18, 51-60.
75. Rachman, S. (1993). Obsessions, responsibility and guilt. Behaviour Research and Therapy, 31, 149-154.
76. Rachman, S., Hodgson, R., & Marks, I. (1971). The treatment of chronic obsessive-compulsive neurosis. Behaviour Research and Therapy, 9, 237-247.
77. Rabavilas, A., Boulougouris, J., & Stefanis, C. (1976). Duration of flooding sessions in the treatment of obsessivecompulsive patients. Behaviour Research and Therapy, 14, 349-355.
78. Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., et al. (2004). Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobics to facilitate extinction of fear. Archives of General Psychiatry, 61, 1136-1144.
79. Rowa, K., Antony, M. M., Summerfeldt, L. J., Purdon, C., Young, L. & Swinson, R. P. (2007). Office-based vs. homebased behavioral treatment for obsessive compulsive disorder: A preliminary study. Behaviour Research and Therapy, 45, 1883-1892.
80. Salkovskis, P. M. (1996). Cognitive-behavioral approaches to the understanding of obsessional problems. In R. Rapee (Ed.), Current controversies in the anxiety disorders (pp. 103-133). New York: Guilford.
81. Simpson, H. B., Foa, E., Liebowitz, M., Ledley, D., Huppert, J., Cahill, S., Vermes, D., Schmidt, A., Hembree, E., Franklin, M., Campeas, R., & Hahn, C. (2008). A randomized controlled trial of cognitive-behavior therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. American Journal of Psychiatry, 165, 621-630.
82. Simpson, H. B., Gorfinkle, K. S., & Liebowitz, M. R. (1999). Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. Journal of Clinical Psychiatry, 60, 584-590.
83. Solomon, R. L., Kamin, L. J., & Wynne, L. C. (1953). Traumatic avoidance learning: The outcomes of several extinction procedures with dogs. Journal of Abnormal Social Psychology, 48, 291-302.
84. Steketee, G. S., Chambless, D. L., & Tran, G. Q. (2001). Effects of Axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Comprehensive Psychiatry, 42, 76-86.
85. Storch, E. A., Merlo, L. J., Bengtson, M., Murphy, T. K., Lewis, M. H., Yang, M. C., et al. (2007). D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. International Clinical Psychopharmacology, 22, 230-237.
86. Taylor, S. (1995). Assessment of obsessions and compulsions: reliability, validity, and sensitivity to treatment effects. Clinical Psychology Review, 15, 261-296.
87. Tenneij, N., van Megen, H., Denys, D., & Westenberg, H. (2005). Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. Journal of Clinical Psychiatry, 66, 1169-1175.
88. Tolin, D. F. & Hannan, S. (2005). The role of the therapist in behavior therapy for OCD. In J. S. Abramowitz & A. C. Houts (Eds.), Concepts and controversies in obsessive-compulsive disorders (pp. 317-332). New York: Springer.
89. Tolin, D. F., Maltby, N., Diefenbach, G. J., Hannan, S. E., & Worhunsky, P. (2004). Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: A wait-list controlled open trial. Journal of Clinical Psychiatry, 65, 922-931.
90. Van Balkom, A. J. L. M., De Haan, E., Van Oppen, P., Spinhoven, P., Hoogduin, K. A. L., & Van Dyck, R. (1998). Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. The Journal of Nervous and Mental Disorders, 186(8), 492-499.
91. Van Oppen, P., & Arntz, A. (1994). Cognitive therapy for obsessive-compulsive disorder. Behaviour Research and Therapy, 32, 79-87.
92. Van Oppen, P., De Haan, E., Van Balkom, A. J. L. M., Spinhoven, P., Hoogduin, K., & Van Dyck, R. (1995). Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behaviour Research and Therapy, 33, 379-390.
93. Walker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002). Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. Journal of Neuroscience, 22, 2343-2351.
94. Warren, R. & Thomas, J. C. (2001). Cognitive-behavior therapy of obsessive-compulsive disorder in private practice: an effectiveness study. Journal of Anxiety Disorders, 15, 277-285.
95. Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., et al. (2008). Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. American Journal of Psychiatry, 165, 335-341.
96. Zohar, J. & Insel, T. R. (1987). Obsessive-compulsive disorder: Psychobiological approaches to diagnosis, treatment, and pathophysiology. Biological Psychiatry, 22, 667-687.